Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Damascus University, Syria.
Department of Endodontics, Faculty of Dentistry, Damascus University, Syria.
Dent Med Probl. 2023 Apr-Jun;60(2):239-246. doi: 10.17219/dmp/151983.
BACKGROUND: Maxillary sinus grafting is considered the most common surgical technique to secure a sufficient bone height for placing dental implants. It is carried out either by making a bony window in the lateral wall of the maxillary sinus (the external procedure) or through the alveolar entrance technique by using alveolar osteotomes (the internal procedure), depending on the quality and quantity of the remaining bone. OBJECTIVES: The aim of the present study was to compare radiologically the amount of bone gain (an increase in bone dimensions) and bone reduction (the loss of the graft volume) obtained by using tricalcium phosphate (TCP) and calcium sulfate (CS) grafts mixed with advanced platelet-rich fibrin (A-PRF). MATERIAL AND METHODS: Nine patients (18 maxillary sinuses) participated in this study, all of whom had bilateral edentulism involving the premolar/molar areas and a bone height of 0.5-5 mm between the sinus floor and the alveolar ridge. Two biomaterials were used in the sinus augmentation procedures. Each patient underwent a bilateral maxillary sinus lift with the use of different bone graft materials - with CS mixed with A-PRF used on one side, and TCP mixed with A-PRF on the other side. The grafting site was selected randomly. Afterward, bone gain and bone reduction were evaluated at the grafting site by using cone-beam computed tomography (CBCT). RESULTS: The mean bone gain on the side treated with TCP mixed with A-PRF was 7.532 ±1.150 mm, and on the side treated with CS mixed with A-PRF side it was 7.961 ±2.781 mm. The comparison of bone gain and bone reduction between the 2 groups showed no statistically significant differences at a 6-month follow-up. CONCLUSIONS: Using CS or TCP mixed with A-PRF was beneficial and safe in the two-stage maxillary sinus lifting procedure. A sufficient amount of bone was obtained for dental implantation.
背景:上颌窦提升术被认为是为放置牙种植体获得足够骨高度的最常见手术技术。根据剩余骨的质量和数量,可以通过在上颌窦侧壁上制作骨窗(外部程序)或通过使用牙槽骨骨凿的牙槽入口技术(内部程序)来进行。
目的:本研究旨在比较使用三钙磷酸盐(TCP)和硫酸钙(CS)与先进血小板丰富纤维蛋白(A-PRF)混合的移植物获得的骨量增加(骨尺寸增加)和骨减少(移植物体积损失)的影像学结果。
材料和方法:本研究共纳入 9 名患者(18 个上颌窦),所有患者均存在双侧磨牙和前磨牙缺失,窦底和牙槽嵴之间的骨高度为 0.5-5mm。在鼻窦增大手术中使用了两种生物材料。每位患者均接受了双侧上颌窦提升术,一侧使用 CS 与 A-PRF 混合,另一侧使用 TCP 与 A-PRF 混合。随机选择移植部位。然后,通过锥形束 CT(CBCT)评估移植部位的骨量增加和骨量减少。
结果:使用 TCP 与 A-PRF 混合的一侧平均骨量增加为 7.532 ±1.150mm,使用 CS 与 A-PRF 混合的一侧为 7.961 ±2.781mm。两组之间的骨量增加和骨量减少比较在 6 个月随访时无统计学差异。
结论:在两阶段上颌窦提升术中,使用 CS 或 TCP 与 A-PRF 混合是有益且安全的。获得了足够的骨量用于牙种植体植入。
J Adv Periodontol Implant Dent. 2018-12-25
Clin Implant Dent Relat Res. 2025-6
Front Bioeng Biotechnol. 2024-10-7